Image

Mediterranean Diet Post-liver Transplantation

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and prevention of fatty liver disease after liver transplantation.

Description

Study Hypotheses

  • A modified Mediterranean diet after liver transplantation results in weight loss, improvement of insulin sensitivity, lipid profiles, blood pressure, BMI, and waist circumference in patients who adhere to the program.
  • A modified Mediterranean diet after liver transplantation results in relative improvement in cardiovascular outcomes in patients who adhere to the program when compared to standard of care.
  • A modified Mediterranean diet after liver transplantation results in relative improvement in 10-year ASCVD risk in patients who adhere to the program when compared to standard of care.
  • A modified Mediterranean diet after liver transplantation decreases the risk of development of NAFLD/NASH/NASH fibrosis in patients who adhere to the program.

Study Design:

  • Single-center, prospective, randomized interventional trial
  • All eligible post-liver transplant patients during the enrollment period will be invited to participate in the trial.
  • All enrolled patients will be randomized to the Dietary Intervention (DI) arm or the Standard of Care (SOC) arm.
  • All patients will be followed for 12 months.

Eligibility

Inclusion Criteria

  • Adult patients ≥ 18 years of age undergoing primary liver transplant
  • Ascites-adjusted BMI ≥ 25 kg/m2
  • Acceptable graft function (total bilirubin level < 5 mg/dL and doppler ultrasound with patent hepatic artery, hepatic veins and portal veins)

Exclusion Criteria

  • Hepatocellular carcinoma (HCC) that did not fulfill Milan criteria as per explant histology
  • Untreated post-transplant vascular complications or biliary strictures
  • Multi-organ transplantation
  • Urine protein excretion ≥2.0 g/day
  • Uncontrolled diabetes mellitus (HbA1c > 10%)
  • Associated medical conditions incompatible with safe participation in a nutritional intervention study, including digestive diseases with fat intolerance, neurological, psychiatric or endocrine disorders
  • Active eating disorder (e.g. bulimia nervosa, anorexia nervosa)
  • History of bariatric surgery
  • Pregnancy or planning on pregnancy in the next year

Study details

Liver Transplantation

NCT04672863

Mayo Clinic

21 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.